Literature DB >> 16258290

A role for G-CSF (granulocyte-colony stimulating factor) in the central nervous system.

Armin Schneider1, Hans-Georg Kuhn, Wolf-Rüdigger Schäbitz.   

Abstract

G-CSF (Granulocyte-colony stimulating factor) is a hematopoietic growth factor that has been known for 20 years, and has been named for its role in the proliferation and differentiation of cells of the myeloic lineage. We have uncovered a novel spectrum of activities of G-CSF in the central nervous system. G-CSF and its receptor are expressed by neurons in many brain regions, and are upregulated upon experimental stroke. In neurons, G-CSF acts anti-apoptotically by activating several protective pathways. In vivo, G-CSF decreases infarct volumes in acute stroke models in rodents. Moreover, G-CSF stimulates neuronal differentiation of adult neural stem cells in the brain, and improves long-term recovery in more chronic stroke models. Thus, G-CSF is a novel neurotrophic factor, and a highly attractive candidate for the treatment of neurodegenerative conditions. Here we discuss this new property of G-CSF in contrast to its known functions in the hematopoietic system, summarize data from other groups on G-CSF's actions in cerebral ischemia, compare G-CSF to Erythropoietin (EPO) in the CNS, and highlight clinical implications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16258290     DOI: 10.4161/cc.4.12.2213

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  57 in total

1.  Neuroprotective therapy using granulocyte colony-stimulating factor for patients with worsening symptoms of compression myelopathy, Part 1: a phase I and IIa clinical trial.

Authors:  Tsuyoshi Sakuma; Masashi Yamazaki; Akihiko Okawa; Hiroshi Takahashi; Kei Kato; Mitsuhiro Hashimoto; Koichi Hayashi; Takeo Furuya; Takayuki Fujiyoshi; Junko Kawabe; Chikato Mannoji; Ryo Kadota; Masayuki Hashimoto; Kazuhisa Takahashi; Masao Koda
Journal:  Eur Spine J       Date:  2011-09-21       Impact factor: 3.134

2.  Translating G-CSF as an Adjunct Therapy to Stem Cell Transplantation for Stroke.

Authors:  Ike dela Peña; Cesar V Borlongan
Journal:  Transl Stroke Res       Date:  2015-12       Impact factor: 6.829

Review 3.  Cell-based therapy in ischemic stroke.

Authors:  David C Hess; Cesar V Borlongan
Journal:  Expert Rev Neurother       Date:  2008-08       Impact factor: 4.618

4.  Methyl-CpG Binding Protein 2 Regulates Microglia and Macrophage Gene Expression in Response to Inflammatory Stimuli.

Authors:  James C Cronk; Noël C Derecki; Emily Ji; Yang Xu; Aaron E Lampano; Igor Smirnov; Wendy Baker; Geoffrey T Norris; Ioana Marin; Nathan Coddington; Yochai Wolf; Stephen D Turner; Alan Aderem; Alexander L Klibanov; Tajie H Harris; Steffen Jung; Vladimir Litvak; Jonathan Kipnis
Journal:  Immunity       Date:  2015-04-21       Impact factor: 31.745

5.  Granulocyte colony-stimulating factor reduced neuropathic pain associated with thoracic compression myelopathy: report of two cases.

Authors:  Masashi Yamazaki; Tsuyoshi Sakuma; Kei Kato; Takeo Furuya; Masao Koda
Journal:  J Spinal Cord Med       Date:  2013-01       Impact factor: 1.985

6.  Granulocyte colony-stimulating factor treatment provides neuroprotection in surgically induced brain injured mice.

Authors:  Nikan H Khatibi; Vikram Jadhav; Mehdi Saidi; Wanqiu Chen; Robert Martin; Gary Stier; Jiping Tang; John H Zhang
Journal:  Acta Neurochir Suppl       Date:  2011

7.  The combined effect of granulocyte-colony stimulating factor (G-CSF) treatment and exercise in rats with spinal cord injury.

Authors:  Chan-Hyuk Park; Kyung-Lim Joa; Mi-Ok Lee; Seung-Hwan Yoon; Myeong-Ok Kim
Journal:  J Spinal Cord Med       Date:  2018-09-19       Impact factor: 1.985

8.  Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer.

Authors:  Debra E Lyon; Ronald Cohen; Huaihou Chen; Debra L Kelly; Nancy L McCain; Angela Starkweather; Hyochol Ahn; Jamie Sturgill; Colleen K Jackson-Cook
Journal:  J Neuroimmunol       Date:  2016-11-13       Impact factor: 3.478

9.  Neuroprotective therapy using granulocyte colony-stimulating factor for acute spinal cord injury: a phase I/IIa clinical trial.

Authors:  Hiroshi Takahashi; Masashi Yamazaki; Akihiko Okawa; Tsuyoshi Sakuma; Kei Kato; Mitsuhiro Hashimoto; Koichi Hayashi; Takeo Furuya; Takayuki Fujiyoshi; Junko Kawabe; Tomonori Yamauchi; Chikato Mannoji; Tomohiro Miyashita; Ryo Kadota; Masayuki Hashimoto; Yasuo Ito; Kazuhisa Takahashi; Masao Koda
Journal:  Eur Spine J       Date:  2012-03-06       Impact factor: 3.134

10.  G-CSF, rt-PA and combination therapy after experimental thromboembolic stroke.

Authors:  Rainer Kollmar; Nils Henninger; Christian Urbanek; Stefan Schwab
Journal:  Exp Transl Stroke Med       Date:  2010-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.